0001950047-24-003351.txt : 20240503 0001950047-24-003351.hdr.sgml : 20240503 20240503161617 ACCESSION NUMBER: 0001950047-24-003351 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 24913315 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER CENTRAL INDEX KEY: 0001237334 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001237334 XXXXXXXX LIVE 0001082554 UNITED THERAPEUTICS CORPORATION 000-26301 1000 Spring Street SILVER SPRING MD 20910 (301) 608-9292 CHRISTOPHER CAUSEY Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

2240 582195.04 44355694 05/03/2024 NASDAQ Common 05/03/2024 Stock Option Exercise Issuer N 2240 05/03/2024 Cash Y 05/03/2024 /s/ Christopher Causey